Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 9Ovarian Neoplasms 3Lymphoma 3Carcinoma, Ovarian Epithelial 3Uveal Melanoma 2Sarcoma 2Rectal Neoplasms 2Prostatic Neoplasms 2Melanoma 2Leukemia 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Choroid Plexus Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Lobular 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Breast Cancer Patients 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Vincristine 2Radiotherapy 2Melphalan 2Ifosfamide 2Etoposide 2Doxorubicin 2Dactinomycin 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1aldesleukin 1Methylprednisolone 1Mesna 1Magnetic Resonance Spectroscopy 1Gene Expression Profiling 1Gelclair 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive, Peripheral × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00514345 2013-08-12

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

National Cancer Institute (NCI)

Unknown
300 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡